24/7 SUPPORT  1.800.887.8100
`
`Visit HCP Site
`
`Prescribing Information
`
`Important Safety Information
`
`Sign in/Register
`
`Relapsing MS
`
`®
`Teva's COPAXONE
`
`®
`Taking Teva's COPAXONE
`
`®
`Shared Solutions
`
`Living With MS
`
`Experience the freedom to...
`
`Be Bold. Be True. Be You.
`
`Celebrating over a year of 3-times-a-week COPAXONE 40 mg
`®
`
`
`Take control with clinically proven results
`
`Make the move
`
`®
`COPAXONE Perspectives
`
`®
`COPAXONE CO-PAY SOLUTIONS
`
`Hear what others are saying
`about 3-times-a-week
`®
`COPAXONE 40 mg.
`
`
`
`Watch videos
`
`If you are eligible, your
`®
`COPAXONE 40 mg co-pay
`could be
`Terms and Conditions
`
`
`
`Find out more
`
`Show Conversation
`
`Voice: On Off
`
`Ask me about COPAXONE®...
`
`Meet Claire—
`Your virtual health assistant, support
`and connection to Shared Solutions®
`
`Use:
`
`®
`COPAXONE (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of
`multiple sclerosis (MS).
`
`®
`IMPORTANT SAFETY INFORMATION ABOUT COPAXONE
`
`®
`Do not take COPAXONE if you are allergic to glatiramer acetate or mannitol.
`
`®
`Some patients report a short-term reaction right after injecting COPAXONE . This reaction can involve flushing (feeling of
`warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms
`®
`IMPORTANT SAFETY INFORMATION ABOUT COPAXONE (glatiramer acetate injection)
`SHOW MORE
`®
`Do not take COPAXONE if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting
`generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the
`®
`COPAXONE . This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety,
`postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If
`and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific
`treatment.
`symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives,
`skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the
`above occurs, do not give yourself any more injections until your doctor tells you to begin again.
`
`MYLAN PHARMS. INC. EXHIBIT 1127 PAGE 1
`
`

`
`Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few
`minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell
`your doctor if you experience chest pain that lasts for a long time or feels very intense.
`
`A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local
`destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.
`
`®
`The most common side effects in studies of COPAXONE are redness, pain, swelling, itching, or a lump at the site of injection,
`®
`flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE . For a
`®
`complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE .
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-
`800-FDA-1088.
`
`®
`Please see full Prescribing Information for Teva’s COPAXONE .
`
`RELAPSING MS
`
`®
`TEVA'S COPAXONE
`
`®
`TAKING TEVA'S COPAXONE
`
`®
`SHARED SOLUTIONS
`
`LIVING WITH MS
`
`What is Relapsing MS?
`
`Relapsing MS Symptoms
`
`Relapsing MS Diagnosis
`
`Relapsing MS Treatment
`
`Talk to Your Doctor
`
`Financial Support
`
`Training and Nurse
`Support
`
`Educational Resources
`
`Virtual Health Assistant
`
`3-times-a-week
`®
`COPAXONE 40 mg
`
`®
`Your COPAXONE
`Prescription
`
`Be Proactive About Your
`Prescription
`
`A Therapy With Proven
`Results
`
`How to Start
`
`Preparation
`
`®
`Injecting with autoject 2 for
`glass syringe
`
`®
`Injecting with the COPAXONE
`Pre-filled Syringe
`
`Syringe Storage & Disposal
`
`Tolerability Profile
`
`Injection Tracking
`
`®
`How Teva's COPAXONE
`Works
`
`COPAXONE
`webTracker™
`
`®
`COPAXONE
`Perspectives
`
`Video Library
`
`Resources
`
`Travel Tips
`
`Live Event Locator
`
`Teleconferences
`
`Insurance FAQ
`
`Terms of Use | Accessibility Help | Privacy Notice | Site Map | Contact Us
`
`®
`Injections for 3-times-a-week COPAXONE 40 mg should be at least 48 hours apart.
`
`†
`
`®
`Applies only to daily COPAXONE 20 mg. Certain limits and restrictions apply.
`
`®
`®
`Terms and Conditions for daily COPAXONE include: COPAXONE Co-pay Solutions is open to both new and existing patients who are residents of the US or
`
`®
`Puerto Rico and who have commercial prescription insurance coverage for COPAXONE 20 mg. The offer is not valid for patients covered in whole or in part by
`
`Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription
`
`is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of
`
`any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void in Massachusetts and where otherwise prohibited by law,
`
`taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time
`
`without notice. This program is not health insurance.
`
`MYLAN PHARMS. INC. EXHIBIT 1127 PAGE 2
`
`

`
`††
`
`®
`Applies only to 3-times-a-week COPAXONE 40 mg. Certain limits and restrictions apply.
`
`®
`Terms and Conditions for 3-times-a-week COPAXONE include: COPAXONE Co-pay Solutions is open to both new and existing patients who are residents of the
`
`US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE 40 mg. The offer is not valid for uninsured patients or patients
`
`® ®
`
`covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of
`
`whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be
`
`consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void in Massachusetts and where
`
`otherwise prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or
`
`discontinued at any time without notice. This program is not health insurance.
`
`®
`®
`®
`COPAXONE , COPAXONE CO-PAY SOLUTIONS , and COPAXONE iTracker are registered trademarks of Teva Pharmaceutical Industries Ltd.
`
`®
`Shared Solutions is a registered service mark of Teva Neuroscience, Inc.
`
`COPAXONE webTracker™ is a trademark of Teva Pharmaceutical Industries Ltd.
`
`®
`autoject 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
`
`Apple and iTunes are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.
`
`Android and Google Play are trademarks of Google Inc.
`
`© 2015 Teva Neuroscience, Inc. COP-43010 This site is intended for US residents only.
`
`MYLAN PHARMS. INC. EXHIBIT 1127 PAGE 3